ABAXIS Company Profile (NASDAQ:ABAX)

About ABAXIS (NASDAQ:ABAX)

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:

Sector: Medical
Industry: Advanced Medical Equipment & Technology - NEC
Sub-Industry: Health Care Equipment
Symbol: NASDAQ:ABAX
CUSIP: 00256710
Web: www.abaxis.com

Capitalization:

Market Cap: $1.16 billion
Outstanding Shares: 22,653,000

Average Prices:

50 Day Moving Avg: $51.81
200 Day Moving Avg: $49.66
52 Week Range: $44.12 - $55.95

P/E:

Trailing P/E Ratio: 35.46
Foreward P/E Ratio: 35.42
P/E Growth: 6.71

Sales & Book Value:

Annual Revenue: $227.22 million
Price / Sales: 5.08
Book Value: $11.81 per share
Price / Book: 4.32

Dividend:

Annual Dividend: $0.56
Dividend Yield: 1.1%

Profitability:

EBIDTA: $51.83 million
Net Margins: 14.40%
Return on Equity: 11.37%
Return on Assets: 9.95%

Debt:

Current Ratio: 6.97%
Quick Ratio: 5.81%

Misc:

Average Volume: 111,340 shs.
Beta: 0.83
Short Ratio: 18.92

Frequently Asked Questions for ABAXIS (NASDAQ:ABAX)

What is ABAXIS's stock symbol?

ABAXIS trades on the NASDAQ under the ticker symbol "ABAX."

How often does ABAXIS pay dividends? What is the dividend yield for ABAXIS?

ABAXIS declared a quarterly dividend on Thursday, April 27th. Shareholders of record on Thursday, June 1st will be paid a dividend of $0.14 per share on Thursday, June 15th. This represents a $0.56 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date is Tuesday, May 30th. View ABAXIS's Dividend History.

How were ABAXIS's earnings last quarter?

ABAXIS, Inc. (NASDAQ:ABAX) announced its quarterly earnings results on Thursday, April, 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.33 by $0.00. The business had revenue of $58.20 million for the quarter, compared to analysts' expectations of $58.04 million. ABAXIS had a return on equity of 11.37% and a net margin of 14.40%. The firm's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $0.36 earnings per share. View ABAXIS's Earnings History.

When will ABAXIS make its next earnings announcement?

ABAXIS is scheduled to release their next quarterly earnings announcement on Thursday, July, 27th 2017. View Earnings Estimates for ABAXIS.

Where is ABAXIS's stock going? Where will ABAXIS's stock price be in 2017?

6 equities research analysts have issued twelve-month target prices for ABAXIS's stock. Their forecasts range from $39.00 to $56.50. On average, they anticipate ABAXIS's stock price to reach $47.88 in the next year. View Analyst Ratings for ABAXIS.

Who are some of ABAXIS's key competitors?

Some companies that are related to ABAXIS include Accelerate Diagnostics (AXDX), Natus Medical Incorporated (BABY), Quidel Corporation (QDEL), Mazor Robotics (MZOR), Luminex Corporation (LMNX), GenMark Diagnostics (GNMK), LeMaitre Vascular (LMAT), Accuray Incorporated (ARAY), Pacific Biosciences of California (PACB), Corindus Vascular Robotics (CVRS), ViewRay (VRAY), Cytosorbents Corporation (CTSO), Alliance HealthCare Services (AIQ), Viveve Medical (VIVE), Fulgent Genetic (FLGT), IRIDEX Corporation (IRIX), Cogentix Medical (CGNT) and Neovasc Inc (US) (NVCN).

Who are ABAXIS's key executives?

ABAXIS's management team includes the folowing people:

Clinton H. Severson, Chairman of the Board, Chief Executive Officer
Donald Peter Wood, President, Chief Operating Officer
Ross Taylor, Chief Financial Officer, Vice President - Finance, Secretary
Kenneth P. Aron Ph.D., Chief Technology Officer
Craig M. Tockman, Vice President - Animal Health Sales and Marketing for North America
Achim Henkel, Managing Director of Abaxis Europe GmbH
Vernon Edward Altman, Independent Director
Richard J. Bastiani Ph.D., Independent Director
Michael D. Casey, Independent Director
Henk J. Evenhuis, Independent Director

Who owns ABAXIS stock?

ABAXIS's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Copeland Capital Management LLC (1.45%), Rockefeller Financial Services Inc. (0.85%), AMI Asset Management Corp (0.78%), US Bancorp DE (0.18%), Nisa Investment Advisors LLC (0.08%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own ABAXIS stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh, Richard Bastiani and Vernon E Altman. View Institutional Ownership Trends for ABAXIS.

Who sold ABAXIS stock? Who is selling ABAXIS stock?

ABAXIS's stock was sold by a variety of institutional investors in the last quarter, including Capstone Asset Management Co.. Company insiders that have sold ABAXIS stock in the last year include Achim Henkel, Clinton Severson, Donald Peter Wood, Kenneth Aron, Prithipal Singh and Richard Bastiani. View Insider Buying and Selling for ABAXIS.

Who bought ABAXIS stock? Who is buying ABAXIS stock?

ABAXIS's stock was acquired by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, AMI Asset Management Corp, Eqis Capital Management Inc., Rockefeller Financial Services Inc., State of Alaska Department of Revenue, US Bancorp DE, Aperio Group LLC and Atria Investments LLC. View Insider Buying and Selling for ABAXIS.

How do I buy ABAXIS stock?

Shares of ABAXIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ABAXIS's stock price today?

One share of ABAXIS stock can currently be purchased for approximately $51.00.

MarketBeat Community Rating for ABAXIS (NASDAQ ABAX)

Community Ranking:		1.4 out of 5 ()
Outperform Votes:		85 (Vote Outperform)
Underperform Votes:		213 (Vote Underperform)
Total Votes:		298

MarketBeat's community ratings are surveys of what our community members think about ABAXIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for ABAXIS (NASDAQ:ABAX) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$47.88 (6.13% downside)

Analysts' Ratings History for ABAXIS (NASDAQ:ABAX)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
7/14/2017	Stifel Nicolaus	Reiterated Rating	Hold	$48.00	Low
6/9/2017	Aegis	Initiated Coverage	Hold	$56.50	High
2/14/2017	Canaccord Genuity	Reiterated Rating	Hold	$48.00	N/A
2/1/2017	Seaport Global Securities	Upgrade	Buy		N/A
11/30/2016	Northcoast Research	Downgrade	Buy -> Neutral		N/A
8/16/2016	Credit Suisse Group	Reiterated Rating	Sell	$39.00	N/A
7/22/2016	Feltl & Co.	Downgrade	Hold -> Sell		N/A
4/1/2016	CL King	Initiated Coverage	Neutral		N/A
1/29/2016	Piper Jaffray Companies	Lower Price Target	Neutral	$49.00 -> $45.00	N/A
10/21/2015	Bank of America Corporation	Downgrade	Neutral -> Underperform	$66.00 -> $39.00	N/A

(Data available from 7/24/2015 forward)

Earnings History for ABAXIS (NASDAQ:ABAX)

Earnings by Quarter for ABAXIS (NASDAQ:ABAX)

Earnings History by Quarter for ABAXIS (NASDAQ ABAX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/27/2017		$0.33					N/A
4/27/2017	Q4 2017	$0.33	$0.33	$58.04 million	$58.20 million	View	N/A
1/26/2017	Q317	$0.31	$0.30	$54.36 million	$52.80 million	View	N/A
10/25/2016	Q217	$0.35	$0.34	$60.69 million	$58.60 million	View	Listen
7/21/2016	Q117	$0.32	$0.30	$58.70 million	$57.70 million	View	Listen
4/28/2016	Q416	$0.32	$0.36	$56.62 million	$57.00 million	View	Listen
1/28/2016	Q316	$0.33	$0.35	$58.52 million	$52.90 million	View	Listen
10/27/2015	Q216	$0.32	$0.34	$56.20 million	$56.00 million	View	Listen
7/23/2015	Q116	$0.28	$0.31	$53.75 million	$53.10 million	View	Listen
4/30/2015	Q415	$0.27	$0.17	$55.62 million	$52.00 million	View	N/A
1/29/2015	Q315	$0.25	$0.26	$51.70 million	$59.50 million	View	N/A
10/21/2014	Q215	$0.23	$0.24	$50.55 million	$53.90 million	View	Listen
7/24/2014	Q115	$0.19	$0.21	$46.95 million	$47.50 million	View	N/A
4/24/2014	Q414	$0.19	$0.17	$45.74 million	$42.04 million	View	N/A
1/31/2014	Q314	$0.20	$0.14	$49.47 million	$40.00 million	View	N/A
10/22/2013	Q114	$0.21	$0.18	$48.60 million	$45.90 million	View	N/A
7/25/2013	Q1 2014	$0.23	$0.14	$49.13 million	$43.20 million	View	Listen
4/25/2013	Q4 2013	$0.26	$0.30	$52.47 million	$50.00 million	View	Listen
1/31/2013	Q3 2013	$0.20	$0.22	$45.75 million	$49.80 million	View	Listen
10/23/2012		$0.18	$0.18			View	N/A
7/26/2012		$0.17	$0.13			View	N/A
4/26/2012		$0.16	$0.21			View	N/A
1/26/2012		$0.16	$0.13			View	N/A
10/25/2011		$0.14	$0.15			View	N/A
7/28/2011		$0.16	$0.10			View	N/A
4/28/2011		$0.16	$0.15			View	N/A
1/27/2011		$0.18	$0.17			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for ABAXIS (NASDAQ:ABAX)

2017 EPS Consensus Estimate: $1.29
2018 EPS Consensus Estimate: $1.39

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	1	$0.34	$0.34	$0.34
Q2 2017	1	$0.34	$0.34	$0.34
Q3 2017	2	$0.29	$0.32	$0.31
Q4 2017	2	$0.27	$0.33	$0.30
Q1 2018	1	$0.33	$0.33	$0.33
Q2 2018	1	$0.38	$0.38	$0.38
Q3 2018	1	$0.31	$0.31	$0.31
Q4 2018	1	$0.37	$0.37	$0.37

(Data provided by Zacks Investment Research)

Current Dividend Information for ABAXIS (NASDAQ:ABAX)

Most Recent Dividend:	6/15/2017
Annual Dividend:	$0.56
Dividend Yield:	1.10%
Payout Ratio:	39.16% (Trailing 12 Months of Earnings) 45.90% (Based on This Year's Estimates) 38.89% (Based on Next Year's Estimates)

Dividend Payments by Quarter for ABAXIS (NASDAQ:ABAX)

Dividend History by Quarter for ABAXIS (NASDAQ ABAX)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/27/2017	quarterly	$0.14	1.24%	5/30/2017	6/1/2017	6/15/2017
1/26/2017	quarterly	$0.14	1.13%	2/27/2017	3/1/2017	3/15/2017
10/28/2016	quarterly	$0.14	1.17%	11/29/2016	12/1/2016	12/15/2016
7/21/2016	quarterly	$0.12	1.04%	8/30/2016	9/1/2016	9/15/2016
4/28/2016	quarterly	$0.12	1.06%	6/1/2016	6/3/2016	6/17/2016
1/28/2016	quarterly	$0.11	1.01%	3/1/2016	3/3/2016	3/17/2016
11/3/2015	quarterly	$0.11	0.84%	12/1/2015	12/3/2015	12/17/2015
7/23/2015	quarterly	$0.11	0.9%	9/1/2015	9/3/2015	9/17/2015
4/30/2015	quarterly	$0.11	0.79%	6/2/2015	6/4/2015	6/18/2015
1/30/2015	quarterly	$0.10	0.65%	2/27/2015	3/3/2015	3/17/2015
10/23/2014	quarterly	$0.10	0.82%	11/13/2014	11/17/2014	12/16/2014
7/24/2014	quarterly	$0.10	0.86%	8/29/2014	9/3/2014	9/17/2014
4/24/2014	quarterly	$0.10		5/30/2014	6/3/2014	6/17/2014
12/6/2012	special	$1.00		12/13/2012	12/17/2012	12/28/2012

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for ABAXIS (NASDAQ:ABAX)

Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 98.34%

Institutional Ownership by Quarter for ABAXIS (NASDAQ:ABAX)

Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/26/2017	Achim Henkel	Insider	Sell	650	$48.87	$31,765.50
5/8/2017	Achim Henkel	Director	Sell	8,650	$47.75	$413,037.50
2/2/2017	Richard Bastiani	Director	Sell	4,000	$51.12	$204,480.00
12/6/2016	Clinton Severson	CEO	Sell	15,000	$51.35	$770,250.00
12/2/2016	Kenneth Aron	Insider	Sell	5,000	$51.09	$255,450.00
9/9/2016	Clinton Severson	CEO	Sell	2,000	$48.29	$96,580.00
9/8/2016	Prithipal Singh	Director	Sell	1,000	$49.50	$49,500.00
8/25/2016	Prithipal Singh	Director	Sell	1,500	$50.30	$75,450.00
8/24/2016	Donald Peter Wood	Insider	Sell	8,500	$50.21	$426,785.00
6/9/2016	Richard Bastiani	Director	Sell	5,000	$46.75	$233,750.00
5/17/2016	Achim Henkel	Director	Sell	5,000	$44.43	$222,150.00
5/9/2016	Henk Evenhuis	Director	Sell	3,000	$45.00	$135,000.00
2/9/2016	Vernon E Altman	Director	Buy	303	$39.87	$12,080.61
12/8/2015	Craig Tockman	VP	Sell	560	$54.44	$30,486.40
2/9/2015	Prithipal Singh	Director	Sell	2,500	$60.50	$151,250.00
12/8/2014	Kenneth Aron	CTO	Sell	2,000	$56.68	$113,360.00
11/25/2014	Clinton Severson	CEO	Sell	2,286	$56.00	$128,016.00
11/13/2014	Clinton Severson	CEO	Sell	10,000	$55.00	$550,000.00
11/5/2014	Clinton Severson	CEO	Sell	10,000	$54.00	$540,000.00
11/3/2014	Alberto Santa Ines	CFO	Sell	1,652	$53.09	$87,704.68
11/3/2014	Clinton Severson	CEO	Sell	5,000	$53.00	$265,000.00
10/31/2014	Clinton Severson	CEO	Sell	10,000	$51.50	$515,000.00
8/12/2014	Richard Bastiani	Director	Sell	1,000	$45.40	$45,400.00
7/30/2014	Alberto Santa Ines	CFO	Sell	10,738	$47.81	$513,383.78
7/29/2014	Alberto Santa Ines	CFO	Sell	17,293	$48.01	$830,236.93
6/5/2014	Richard Bastiani	Director	Sell	2,000	$42.10	$84,200.00
6/3/2014	Richard Bastiani	Director	Sell	4,000	$41.88	$167,520.00
5/22/2014	Achim Henkel	Director	Sell	8,500	$41.63	$353,855.00
5/14/2014	Henk Evenhuis	Director	Sell	4,000	$44.06	$176,240.00
5/1/2014	Henk Evenhuis	Director	Sell	4,500	$41.00	$184,500.00
3/4/2014	Vladimir Ostoich	VP	Sell	9,800	$38.53	$377,594.00
2/24/2014	Kenneth Aron	CTO	Sell	1,000	$38.98	$38,980.00
2/13/2014	Donald Peter Wood	COO	Sell	8,864	$38.50	$341,264.00
6/7/2013	Clinton Severson	CEO	Sell	10,000	$44.50	$445,000.00
6/7/2013	Martin Mulroy	Insider	Sell	14,000	$44.80	$627,200.00
5/22/2013	Kenneth Aron	CTO	Sell	4,200	$43.28	$181,776.00
5/7/2013	Achim Henkel	Director	Sell	5,000	$44.07	$220,350.00
3/1/2013	Achim Henkel	Director	Sell	1,000	$42.85	$42,850.00
2/26/2013	Martin Mulroy	Insider	Sell	12,000	$41.84	$502,080.00
2/5/2013	Kenneth Aron	CTO	Sell	40,000	$44.13	$1,765,200.00
2/4/2013	Martin Mulroy	Insider	Sell	12,000	$43.97	$527,640.00
11/23/2012	Richard Bastiani	Director	Sell	5,000	$36.60	$183,000.00

(Data available from 1/1/2013 forward)

Headline Trends for ABAXIS (NASDAQ:ABAX) Latest Headlines for ABAXIS (NASDAQ:ABAX)

Source:

Date	Headline
	ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : July 21, 2017 finance.yahoo.com - July 21 at 4:27 PM
	Zacks: Brokerages Expect ABAXIS, Inc. (NASDAQ:ABAX) to Post $0.32 EPS www.americanbankingnews.com - July 21 at 12:28 PM
	Veterinary Chemistry Analyzer Market by Product Application & Animal - Global Forecast to 2022 www.bizjournals.com - July 21 at 1:27 AM
	ABAXIS, Inc. (NASDAQ:ABAX) Set to Announce Quarterly Earnings on Thursday www.americanbankingnews.com - July 20 at 7:51 AM
	Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More finance.yahoo.com - July 19 at 3:20 PM
	Abaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday ... www.prnewswire.com - July 18 at 3:21 PM
	Abaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday, July 27, 2017 finance.yahoo.com - July 18 at 3:21 PM
	ABAXIS, Inc. (ABAX) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - July 17 at 7:30 AM
	ABAXIS, Inc. (NASDAQ:ABAX) Given Hold Rating at Stifel Nicolaus www.americanbankingnews.com - July 15 at 11:18 AM
	Critical Comparison: ABAXIS (ABAX) vs. Accelerate Diagnostics (AXDX) www.americanbankingnews.com - July 14 at 2:32 PM
	ETFs with exposure to ABAXIS, Inc. : July 11, 2017 finance.yahoo.com - July 11 at 4:19 PM
	ABAXIS, Inc. (ABAX) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - July 11 at 12:41 AM
	ABAXIS, Inc. (ABAX) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - July 2 at 12:02 PM
	Abaxis (ABAX) Product Portfolio Strong, Competition Rife finance.yahoo.com - June 30 at 3:24 PM
	ETFs with exposure to ABAXIS, Inc. : June 29, 2017 finance.yahoo.com - June 29 at 3:20 PM
	Zacks: Brokerages Anticipate ABAXIS, Inc. (ABAX) Will Post Quarterly Sales of $60.62 Million www.americanbankingnews.com - June 29 at 11:40 AM
	Analysts Anticipate ABAXIS, Inc. (ABAX) to Post $0.32 Earnings Per Share www.americanbankingnews.com - June 27 at 10:08 AM
	ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q4, 2017 By the Numbers : June 19, 2017 finance.yahoo.com - June 19 at 3:15 PM
	Thermo Fisher Scientific (TMO) and ABAXIS (ABAX) Financial Review www.americanbankingnews.com - June 17 at 10:44 AM
	ABAXIS, Inc. (ABAX) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - June 16 at 7:56 PM
	Aegis Initiates Coverage on Abaxis Inc (ABAX) www.americanbankingnews.com - June 9 at 7:56 AM
	ETFs with exposure to ABAXIS, Inc. : June 6, 2017 finance.yahoo.com - June 6 at 3:19 PM
	ABAXIS, Inc. :ABAX-US: Earnings Analysis: 2017 By the Numbers : June 5, 2017 finance.yahoo.com - June 5 at 12:59 PM
	$60.62 Million in Sales Expected for Abaxis Inc (ABAX) This Quarter www.americanbankingnews.com - June 3 at 9:48 AM
	Veterinary Chemistry Analyzer Market Worth 1,205.2 Million USD by 2022 www.marketwatch.com - June 1 at 3:19 PM
	Abaxis Inc (ABAX) Expected to Announce Earnings of $0.32 Per Share www.americanbankingnews.com - June 1 at 8:10 AM
	Abaxis Inc (ABAX) Insider Sells $31,765.50 in Stock www.americanbankingnews.com - May 31 at 8:36 PM
	Abaxis, Inc. to Present at the Stifel 2017 Dental & Veterinary Conference and Jefferies 2017 Global Healthcare Conference finance.yahoo.com - May 25 at 3:22 PM
	Abaxis Inc (ABAX) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - May 19 at 10:48 PM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : May 15, 2017 finance.yahoo.com - May 15 at 3:16 PM
	Achim Henkel Sells 8,650 Shares of Abaxis Inc (ABAX) Stock www.americanbankingnews.com - May 10 at 11:22 PM
	Zacks: Analysts Expect Abaxis Inc (ABAX) to Post $0.32 EPS www.americanbankingnews.com - May 8 at 10:30 AM
	Form 4 ABAXIS INC For: May 01 Filed by: TOCKMAN CRAIG www.streetinsider.com - May 5 at 3:15 PM
	Abaxis (ABAX) Earning Somewhat Positive Media Coverage, Analysis Finds www.americanbankingnews.com - May 2 at 7:46 AM
	Abaxis Inc (ABAX) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - May 1 at 11:06 PM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : May 1, 2017 finance.yahoo.com - May 1 at 11:59 AM
	Abaxis (ABAX) Earning Somewhat Positive Press Coverage, Analysis Finds www.americanbankingnews.com - April 29 at 8:40 AM
	Edited Transcript of ABAX earnings conference call or presentation 27-Apr-17 8:15pm GMT finance.yahoo.com - April 28 at 3:05 PM
	Abaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In Line finance.yahoo.com - April 28 at 3:05 PM
	Abaxis Inc (ABAX) Posts Earnings Results, Hits Estimates www.americanbankingnews.com - April 27 at 10:26 PM
	Abaxis Inc (ABAX) Declares Quarterly Dividend of $0.14 www.americanbankingnews.com - April 27 at 10:16 PM
	Abaxis Inc. Reveals 9% Drop In Q4 Profit www.nasdaq.com - April 27 at 8:34 PM
	Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend finance.yahoo.com - April 27 at 8:34 PM
	Abaxis tops 4Q profit forecasts finance.yahoo.com - April 27 at 8:34 PM
	Abaxis (ABAX) Receives News Impact Rating of 0.16 www.americanbankingnews.com - April 26 at 9:15 AM
	Abaxis Inc (ABAX) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - April 25 at 12:53 AM
	ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : April 24, 2017 finance.yahoo.com - April 24 at 3:16 PM
	ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : April 21, 2017 finance.yahoo.com - April 21 at 3:08 PM
	Veterinary Diagnostics Market by Product (Instruments and Consumables), Technology (Clinical Biochemistry, … finance.yahoo.com - April 21 at 1:51 AM
	Abaxis To Report Fourth Quarter And Fiscal Year 2017 Financial Results On Thursday, April 27, 2017 finance.yahoo.com - April 19 at 5:19 AM